Zura Bio Limited reported earnings of -$ 0.20 per ZURA share on Oct 27, 2026, falling short of analysts' expectations by
| Report Date | Oct 27, 2026 |
|---|---|
| Forecasted EPS | -$ 0.20 |
| Earnings Per Share (Surprise) | -$ 0.20 (+$ 0.00394) |
| Last Year's EPS | -$ 0.27 |
| EPS YoY Change |
Out of the last 22 earnings reporting periods, Zura Bio Limited beat analysts’ expectations 6 times and fell short of expectations 8 time(s). Zura Bio Limited reported earnings per share of -$ 0.20 in the last report surpassing an estimated EPS of -$ 0.20 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Oct 27, 2026 | -$ 0.20 | -$ 0.20 | -$ 0.21 | |
| Aug 11, 2026 | -$ 0.19 | -$ 0.21 | -$ 0.17 | |
| May 7, 2026 | -$ 0.17 | -$ 0.22 | -$ 0.19 | |
| Mar 19, 2026 | -$ 0.18 | -$ 0.49 | -$ 0.14 | |
| Nov 13, 2025 | -$ 0.19 | -$ 0.21 | -$ 0.26 | |
| Aug 14, 2025 | -$ 0.19 | -$ 0.17 | -$ 0.17 | |
| May 8, 2025 | -$ 0.17 | -$ 0.19 | -$ 0.02 | |
| Mar 25, 2025 | -$ 0.16 | -$ 0.14 | -$ 0.19 | |
| Nov 7, 2024 | -$ 0.14 | -$ 0.26 | -$ 0.18 | |
| Aug 13, 2024 | -$ 0.13 | -$ 0.17 | -$ 1.31 | |
| May 9, 2024 | -$ 0.23 | -$ 0.02 | -$ 2.76 | |
| Mar 26, 2024 | -$ 0.23 | -$ 0.19 | -$ 0.27 | |
| Nov 13, 2023 | -$ 0.25 | -$ 0.18 | -$ 0.06 | |
| Aug 14, 2023 | -$ 0.25 | -$ 1.31 | -$ 0.05 | |
| May 12, 2023 | -$ 2.76 | -$ 2.76 | $ 0.00857 | |
| Mar 31, 2023 | - | -$ 0.27 | $ 0.0474 | |
| Sep 30, 2022 | - | -$ 0.06 | $ 0.3355 | |
| Jun 30, 2022 | - | -$ 0.05 | $ 0.00 | |
| Mar 30, 2022 | - | $ 0.00857 | - | - |
| Dec 30, 2021 | - | $ 0.0474 | - | - |
Zura Bio Limited’s stock was trading at $ 3.56 on Oct 26, 2026 a day before the last earnings report was released.Following the release of the earnings report, ZURA’s price increased to $ 4.35 on Oct 28, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Oct 27, 2026 | -$ 0.20 | $ 3.56 | $ 4.35 | |
| Aug 11, 2026 | -$ 0.21 | $ 5.63 | $ 5.78 | |
| May 7, 2026 | -$ 0.22 | $ 4.89 | $ 4.79 | |
| Mar 19, 2026 | -$ 0.49 | $ 5.99 | $ 5.50 | |
| Nov 13, 2025 | -$ 0.21 | $ 4.63 | $ 4.08 | |
| Aug 14, 2025 | -$ 0.17 | $ 1.59 | $ 1.66 | |
| May 8, 2025 | -$ 0.19 | $ 1.23 | $ 1.21 | |
| Mar 25, 2025 | -$ 0.14 | $ 1.35 | $ 1.34 | |
| Nov 7, 2024 | -$ 0.26 | $ 4.30 | $ 4.58 | |
| Aug 13, 2024 | -$ 0.17 | $ 3.37 | $ 3.25 | |
| May 9, 2024 | -$ 0.02 | $ 4.71 | $ 4.68 | |
| Mar 26, 2024 | -$ 0.19 | $ 2.40 | $ 2.32 | |
| Nov 13, 2023 | -$ 0.18 | $ 4.28 | $ 4.40 | |
| Aug 14, 2023 | -$ 1.31 | $ 6.84 | $ 6.80 | |
| May 12, 2023 | -$ 2.76 | $ 7.43 | $ 5.50 | |
| Mar 31, 2023 | -$ 0.27 | $ 15.82 | $ 14.20 |
Zura Bio Limited released its most recent earnings reports in October 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Zura Bio Limited beat analysts’ expectations during the last earnings period by
